Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Biomedicines|October 27, 2022
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical ManifestationClaudio Tana, Francesco Cinetto, Cesare Mantini, et al.
Life (Basel, Switzerland)|May 27, 2026
OUtcome and Clinical Characteristics of Primary Headache in Patients with Sarcoidosis: The OUCH! StudyClaudio Tana, Nicol Bernardinello, Giacomo Giulianelli, et al.
Journal of Clinical Medicine|February 15, 2022
Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-AnalysisUgo Grossi, Gaetano Gallo, Gian Luca Di Tanna, et al.
Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.
Biomedicines|July 27, 2024
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative ReviewHelena Buso, Claudia Discardi, Patrick Bez, et al.
Atherosclerosis|March 15, 2020
l-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cellsMarcello Rattazzi, Maristella Donato, Elisa Bertacco, et al.
Journal of Clinical Immunology|January 16, 2019
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter StudyFederica Pulvirenti, Francesco Cinetto, Antonio Pecoraro, et al.
Environment International|June 24, 2026
Differential effects of legacy and new-generation perfluoro-alkyl substances on in vitro differentiation and immunoglobulins production by B cellsSamuela Carraro, Andrea Di Nisio, Maria Piazza, et al.
Frontiers in Immunology|October 23, 2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022Cinzia Milito, Federica Pulvirenti, Giulia Garzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 5, 2009
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosisCarmela Gurrieri, Francesco Piazza, Marianna Gnoato, et al.
Pageof 9